中文速读
本研究使用Entranster-in vivo转染试剂进行体内实验,通过CCK-8 assay检测细胞活力,研究新城疫病毒对高表达α2,6-唾液酸的结肠癌SW620细胞的溶瘤效果。
小鼠瘤内肿瘤SW620SW480
α2,6-linked sialic acid serves as a high-affinity receptor for cancer oncolytic virotherapy with Newcastle disease virus
Qian Li 1 , Ding Wei 1 , Fei Feng 1 , Xi-Long Wang 1 , Can Li 1 , Zhi-Nan Chen 2 , Huijie Bian 3
- 1 Department of Cell Biology, National Translational Science Center for Molecular Medicine, Fourth Military Medical University, No. 169, Changle West Road, Xi’an, 710032, China.
- 2 Department of Cell Biology, National Translational Science Center for Molecular Medicine, Fourth Military Medical University, No. 169, Changle West Road, Xi’an, 710032, China. znchen@fmmu.edu.cn.
- 3 Department of Cell Biology, National Translational Science Center for Molecular Medicine, Fourth Military Medical University, No. 169, Changle West Road, Xi’an, 710032, China. hjbian@fmmu.edu.cn.
Abstract
Purpose: Newcastle disease virus (NDV) has been applied to oncolytic virotherapy for decades due to its naturally oncolytic property. In spite of the substantiation of the sialic acid receptors of NDV on host cells, knowledge of preference of sialic acid linkage in viral attachment and oncolytic effect is lacking and imperative to be elucidated.
Methods: Surface plasmon resonance analysis and competitive inhibition with sialylated glycan receptor analogues were used to determine the affinity and the preference of sialic acid receptor. Treatments of sialyltransferase inhibitors and linkage-specific sialidases and transfection with sialyltransferase expression vector were performed to regulate sialic acids levels.
Results: We demonstrated that sialic acid was essential for NDV binding and infection of tumor cells. α2,6-linked sialic acid served as a high-affinity receptor for NDV and the ST6Gal I sialyltransferase that synthesizes α2-6 linkage of sialylated N-linked glycans in CHO-K1 cells promoted NDV binding and cytopathic effect. More importantly, an enhanced antitumor effect of NDV on aggressive SW620 colorectal carcinoma cells with high-level of cell surface α2,6-sialylation, but not SW480 cells with relative low-level of α2,6-sialylation, was observed both in vitro and in vivo.
Conclusions: The study provides evidence of optimized therapeutic strategy in oncolytic virotherapy via partly defining α2,6-sialylated receptor as a “cellular marker” for NDV.
Keywords: NDV; Oncolytic effect; ST6Gal I; Sialic acid receptors.
Cell Counting Kit-8 (CCK-8) 已有 26 篇已发表文献
同类研究
- Biomed Pharmacother. 2022 Oct;154:113529.doi: 10.1016/j.biopha.2022.113529. Epub 2022 Aug 26. (IF7.419) Praeruptorin B i…
- Front Oncol. 2022 Jul 14;12:882202.doi: 10.3389/fonc.2022.882202. eCollection 2022. (IF5.738) SETD3 Methyltransferase Re…
- J Cell Mol Med .2019 Sep;23(9):5907-5919.doi: 10.1111/jcmm.14386. Long non-coding RNA NR2F1-AS1 promoted proliferation a…
- J Cell Physiol.2019 Feb 14. doi: 10.1002/jcp.28314. MFGE8 protects against CCl 4 -induced liver injury by reducing apopt…
- Mol Med Rep.2017 Oct;16(4):4593-4602. doi: 10.3892/mmr.2017.7201. CD147 blockade as a potential and novel treatment of g…
